Docoh
Loading...

HSDT Helius Medical

News

From Benzinga Pro
Noble Capital Markets Downgrades Helius Medical Tech to Market Perform
15 Nov 21
News, Downgrades, Analyst Ratings
Noble Capital Markets analyst Joe Gomes downgrades Helius Medical Tech (NASDAQ:HSDT) from Outperform to Market Perform.
Overview Of Value Stocks In The Healthcare Sector
15 Nov 21
News
The Meaning Behind Value Stocks
76 Biggest Movers From Yesterday
11 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share.
Helius Medical Tech Q3 EPS $(2.01) Misses $(1.75) Estimate, Sales $109.00K Beat $80.00K Estimate
10 Nov 21
Earnings, News
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.75) by 14.86 percent. This is a 28.21 percent increase over losses of $(2.80) per share
55 Stocks Moving In Wednesday's Mid-Day Session
10 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%
10 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Wednesday, the Dow traded down 0.07% to 36,293.80 while the NASDAQ fell 0.23% to 15,850.04. The S&P also fell, dropping 0.05% to 4,682.75.
Earnings Scheduled For November 10, 2021
10 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Helius Medical Technologies Launches Therapeutic Experience Program
8 Nov 21
News
Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the launch of its Therapeutic Experience Program
Helius Medical Technologies, Inc. Receives PoNS Market Authorization In Australia
4 Nov 21
News, Global
Helius Medical Technologies, Inc. (NASDAQ:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it received market authorization from the Australian Therapeutic Goods
Helius Medical Technologies To Present At Benzinga Healthcare Small Cap Conference Wednesday, Sept. 29 At 1:35 p.m. EDT
22 Sep 21
News, Events
Helius Medical Technologies, Inc. (NASDAQ:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief

Press releases

From Benzinga Pro
Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021
15 Nov 21
News, Press Releases
NEWTOWN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (Helius), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff, President and Chief
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
12 Nov 21
Markets, Press Releases
NEWTOWN, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the closing of its
Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock
9 Nov 21
Press Releases
NEWTOWN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has commenced a
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site
8 Nov 21
Health Care, Press Releases, General
-- Multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects' adherence to PoNS® therapy for gait improvement in Multiple Sclerosis ---- Program to include 10-12
Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia
4 Nov 21
Health Care, Press Releases
NEWTOWN, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it received market
Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021
1 Nov 21
News, Press Releases
NEWTOWN, Pa., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the Company will
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
29 Oct 21
Markets, Press Releases
NEWTOWN, Pa., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that, effective October
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference
12 Oct 21
News, Press Releases
NEWTOWN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff,
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference
22 Sep 21
News, Press Releases
NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff,
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
14 Sep 21
News, Management, Press Releases
NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
7 Sep 21
News, Press Releases
NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that
Better For You Wellness Appoints Montel Williams, Leslie Bumgarner, Joseph Watson, David Deming, and Dr. Nicola Finley, MD to its Board of Directors
2 Sep 21
News, Restaurants, Management, Press Releases, General
Columbus, Ohio, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Better For You Wellness, Inc., formerly known as Fast Track Solutions, Inc., (OTC:FTRK) ("Better For You Wellness" or the "Company"), an Ohio-based blank check